ConductScience.org, home

Paper · 36088310

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132756809Prevalence and correlates of major depressive disorder: a systematic review.Braz J Psychiatry2020https://conductscience.org/library/papers/32756809PubMed
231499373Focusing on insomnia symptoms to better understand depression: A STAR*D report.J Affect Disord2020https://conductscience.org/library/papers/31499373PubMed
334168579Prevalence of Major Depressive Disorder Among Adults in China: A Systematic Review and Meta-Analysis.Front Psychiatry2021https://conductscience.org/library/papers/34168579PubMed
430058415Circadian genes in major depressive disorder.World J Biol Psychiatry2020https://conductscience.org/library/papers/30058415PubMed
533223065Sleep and Mood Disorders Among Youth.Child Adolesc Psychiatr Clin N Am2021https://conductscience.org/library/papers/33223065PubMed
632715964Predicting Incident Treatment-Resistant Depression: A Model Designed for Health Systems of Care.J Manag Care Spec Pharm2020https://conductscience.org/library/papers/32715964PubMed
729782076Effect of insomnia treatments on depression: A systematic review and meta-analysis.Depress Anxiety2018https://conductscience.org/library/papers/29782076PubMed
834024690Ayurveda management of Major Depressive Disorder: A case study.J Ayurveda Integr Med2021https://conductscience.org/library/papers/34024690PubMed
922553134Comparative effectiveness of second-generation antidepressants for accompanying anxiety, insomnia, and pain in depressed patients: a systematic review.Depress Anxiety2012https://conductscience.org/library/papers/22553134PubMed
103013503212-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25-50 mg/day) versus escitalopram (10-20 mg/day) in out-patients with severe generalized anxiety disorder.Eur Neuropsychopharmacol2018https://conductscience.org/library/papers/30135032PubMed
1134419186Circadian rhythm sleep-wake disturbances and depression in young people: implications for prevention and early intervention.Lancet Psychiatry2021https://conductscience.org/library/papers/34419186PubMed
1231735410Is sleep disturbance linked to short- and long-term outcomes following treatments for recurrent depression?J Affect Disord2020https://conductscience.org/library/papers/31735410PubMed
1331046480Pharmacological treatment for insomnia in patients with major depressive disorder.Expert Opin Pharmacother2019https://conductscience.org/library/papers/31046480PubMed
1430292731Sleep Disorders.Am J Med2019https://conductscience.org/library/papers/30292731PubMed
1528044944A pragmatic approach to the diagnosis and treatment of mixed features in adults with mood disorders.CNS Spectr2016https://conductscience.org/library/papers/28044944PubMed
1633530453Measuring Subjective Sleep Quality: A Review.Int J Environ Res Public Health2021https://conductscience.org/library/papers/33530453PubMed
1732853897The associations of insomnia symptoms and chronotype with daytime sleepiness, mood symptoms and suicide risk in adolescents.Sleep Med2020https://conductscience.org/library/papers/32853897PubMed
1833714174Emerging role of microRNAs in major depressive disorder and its implication on diagnosis and therapeutic response.J Affect Disord2021https://conductscience.org/library/papers/33714174PubMed
1916978649The association of insomnia with anxiety disorders and depression: exploration of the direction of risk.J Psychiatr Res2006https://conductscience.org/library/papers/16978649PubMed
2031003451Clinical Characteristics of Obstructive Sleep Apnea in Psychiatric Disease.J Clin Med2019https://conductscience.org/library/papers/31003451PubMed

papers-2026-11-12-0.1.0

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/papers/v1/36088310/references